Please login to the form below

Not currently logged in
Email:
Password:

CSL

This page shows the latest CSL news and features for those working in and with pharma, biotech and healthcare.

Roche highlights Hemlibra data as key FDA date approaches

Roche highlights Hemlibra data as key FDA date approaches

every few days, such as Shire’s Adynovate, Biogen’s Eloctate, Bayer’s Kovaltry and CSL Behring’s Afstyla, uptake hasn’t been as quick as hoped.

Latest news

More from news
Approximately 3 fully matching, plus 40 partially matching documents found.

Latest Intelligence

  • Pharma deals continue to slide Pharma deals continue to slide

    425 (upfront 80). Calimmune (US). CSL (AU). Company acquisition. Preclinical haematopoietic stem cell therapy for sickle cell disease.

  • Deal Watch January 2017 Deal Watch January 2017

    625. Momenta. CSL. Licence. M230 immuno-modulator of Fc receptors. 600. ImmuNext.

  • Pharma deals in June 2015 Pharma deals in June 2015

    85. BioCryst Pharmaceuticals/ CSL. RAPIVAB (peramivir injection) for the treatment of influenza (marketed).

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    318. Novartis/CSL. Asset purchase. Influenza vaccines. 275. Five Prime/GSK. Expansion of collaboration.

  • Modern anticoagulants threaten status quo Modern anticoagulants threaten status quo

    Parenterally administered DTIs. Four parenterally administered DTIs are currently available on the market: lepirudin (Refludan; CSL Behring), desirudin (Revasc; Novartis), bivalirudin (Angiox; Biogen Idec) and argatroban (Novastan; Mitsubishi

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Bartenbach adds to healthcare management team Bartenbach adds to healthcare management team

    Bartenbach adds to healthcare management team. Anja Treiber has worked with CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma. ... In the last two years, Treiber has focused on international pharma clients including CSL Behring, Novo Nordisk,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics